Moderna
MRNA
#1162
Rank
NZ$27.90 B
Marketcap
$72.52
Share price
-3.59%
Change (1 day)
-43.63%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$27.90 Billion

As of December 2024 Moderna has a market cap of NZ$27.90 Billion. This makes Moderna the world's 1162th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$27.90 B-53.46%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Dec 2nd, 2024 the market cap of Moderna was reported to be:

NZ$29.16 Billion
by Yahoo Finance info icon info icon
NZ$29.16 Billion
by CompaniesMarketCap info icon info icon
NZ$28.94 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.18 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$440.18 B 1,477.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$55.11 B 97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$358.95 B 1,186.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$5.68 B-79.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$628.65 B 2,152.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.06 B-81.87%๐Ÿ‡บ๐Ÿ‡ธ USA